Fifth Third Bancorp
NKTR icon

Fifth Third Bancorp’s Nektar Therapeutics NKTR Stock Holding History

Fifth Third Bancorp’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$977 Buy
+14
New +$1.02K ﹤0.01% 4173
2023
Q1 		– Sell
-210
Closed -$7.11K – 2812
2022
Q4 		$7.11K Buy
210
+41
+24% +$1.98K ﹤0.01% 2083
2022
Q3 		$8K Buy
169
+28
+20% +$1.67K ﹤0.01% 2028
2022
Q2 		$8K Buy
+141
New +$8.9K ﹤0.01% 2080
2021
Q4 		– Sell
-17
Closed -$5K – 2753
2021
Q3 		$5K Buy
+17
New +$4.09K ﹤0.01% 2206
2020
Q2 		– Sell
-4
Closed -$1K – 2188
2020
Q1 		$1K Sell
4
-7
-64% -$2.17K ﹤0.01% 2054
2019
Q4 		$3K Sell
11
-31
-74% -$8.99K ﹤0.01% 2018
2019
Q3 		$12K Sell
42
-27
-39% -$9.9K ﹤0.01% 1760
2019
Q2 		$37K Buy
69
+63
+1,050% +$31.6K ﹤0.01% 1457
2019
Q1 		$3K Sell
6
-12
-67% -$7.11K ﹤0.01% 2012
2018
Q4 		$9K Buy
18
+12
+200% +$7.24K ﹤0.01% 1807
2018
Q3 		$5K Buy
6
+3
+100% +$2.56K ﹤0.01% 1992
2018
Q2 		$2K Sell
3
-1
-25% -$1.15K ﹤0.01% 2184
2018
Q1 		$6K Buy
+4
New +$5.15K ﹤0.01% 2024
2016
Q1 		– Sell
-25
Closed -$6K – 2562
2015
Q4 		$6K Buy
25
+1
+4% +$206 ﹤0.01% 2137
2015
Q3 		$4K Buy
24
+9
+60% +$1.59K ﹤0.01% 2378
2015
Q2 		$3K Buy
+15
New +$2.58K ﹤0.01% 2458

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fifth Third Bancorp's NKTR Position: Q2 2026 in Review

Fifth Third Bancorp opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 14 shares worth $977. The stake represents ﹤0.01% of the portfolio and ranks #4173 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in NKTR as recently as Q4 2022.

Fifth Third Bancorp first reported a position in NKTR in Q2 2015 and has held it in 17 quarters since. The position peaked at $37K in Q2 2019. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Fifth Third Bancorp held 14 shares of Nektar Therapeutics worth $977 as of Q2 2026.
  • Nektar Therapeutics was a new Fifth Third Bancorp position in Q2 2026.
  • Nektar Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4173 holding.
  • Fifth Third Bancorp first reported a position in Nektar Therapeutics in Q2 2015 and has held it in 17 quarters since.
  • Fifth Third Bancorp's Nektar Therapeutics position peaked at $37K in Q2 2019.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.